Contec Medical Systems Co.,Ltd (SHE:300869)
China flag China · Delayed Price · Currency is CNY
11.69
+0.11 (0.95%)
Aug 14, 2026, 3:04 PM CST

SHE:300869 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Net Income
-49.1-24.42-77.9165.77196.2352.35
Depreciation & Amortization
27.3827.3827.9527.5220.5917.86
Other Amortization
0.170.170.02---
Loss (Gain) From Sale of Assets
0.170.170.090.070.260.04
Asset Writedown & Restructuring Costs
----0.0110.72
Loss (Gain) From Sale of Investments
-18.5-18.5-24.11-13.49-54.6-1.58
Provision & Write-off of Bad Debts
-1.35-1.351.44-1.032.020.38
Other Operating Activities
70.2348.88109.132.7-40.98-115.35
Change in Accounts Receivable
-10.46-10.46-13.88148.68-64.49-23.01
Change in Inventory
14.5914.5974.03-85.05-17.39-144.98
Change in Accounts Payable
-10.72-10.72-36.56-78.359.34-93.11
Operating Cash Flow
18.9722.2962.34181.01103.664.65
Operating Cash Flow Growth
-79.57%-64.25%-65.56%74.63%2130.42%-99.22%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Capital Expenditures
-48.36-49.48-54.46-30.74-81.45-106.31
Sale of Property, Plant & Equipment
0.140.140.950.110.250.12
Investment in Securities
144.68224.85-170.24-750-5050
Other Investing Activities
188.0352.27118.0857.6717.375.09
Investing Cash Flow
284.49227.79-105.68-722.96-113.82-51.09

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Short-Term Debt Issued
-27590632.88874.88915.2
Long-Term Debt Issued
----690.1-
Total Debt Issued
268.5627590632.881,565915.2
Short-Term Debt Repaid
--120-377-1.06-787.05-312.1
Long-Term Debt Repaid
--1.43-2.21-1,191-1.87-0.35
Total Debt Repaid
-136.85-121.43-379.21-1,192-788.92-312.45
Net Debt Issued (Repaid)
131.71153.57-289.21-559.54776.06602.75
Common Dividends Paid
-112.9-112.11-127.72-68.7-123.92-102.31
Other Financing Activities
-0.1822.06673.18244.79129.2-666.06
Financing Cash Flow
18.6363.52256.26-383.44781.34-165.62

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Foreign Exchange Rate Adjustments
-28.19-15.184.165.2817.58-2.5
Net Cash Flow
293.9298.42217.08-920.1788.75-214.56

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Free Cash Flow
-29.4-27.197.88150.2822.21-101.66
Free Cash Flow Growth
---94.75%576.62%--
Free Cash Flow Margin
-6.44%-5.81%1.64%20.12%3.12%-11.19%
Free Cash Flow Per Share
-0.07-0.070.020.360.05-0.25
Levered Free Cash Flow
-44.04411.69-449.4870.11-46.16-97.74
Unlevered Free Cash Flow
-13.42435.09-427.4298.3-34.24-95.95

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash Income Tax Paid
12.677.7440.6934.949.960.8
Change in Working Capital
-10.03-10.0325.77-30.52-19.85-259.78